1Miyazawa K,Shimomura T,Naka D. Proteolytic activation of hepatocyte growth factor in response to tissue injury[J].{H}Journal of Biological Chemistry,1994.8966-8970.
2Trebicka J,Hennenberg M,Laleman W. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase[J].{H}HEPATOLOGY,2007.242-253.
3Qin S,Jiang H,Su S. Inhibition of hepatic stellate cell proliferation by bone marrow mesenchymal stem cells via regulation of the cell cycle in rat[J].Exp Ther Med,2012.375-380.
4Ikeda H,Nagashima K,Yanase M. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells[J].{H}American Journal of Physiology Gastrointestinal and Liver Physiology,2003.G880-G886.
5Kim WH,Matsumoto K,Bessho K. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis[J].{H}AMERICAN JOURNAL OF PATHOLOGY,2005.1017-1028.
6Xue F,Zhang JJ,Xu LM. Protective effects of HGF-MSP chimer(metron factor-1) on liver ischemia-reperfusion injury in rat model[J].J Dig Dis,2010.299-305.
7Miyazawa K,Shimomura T. Proteolytic cascade for activation of hepatocyte growth factor in response to tissue injury[J].{H}SEIKAGAKU,1995.381-385.
8Kato M,Hashimoto T,Shimomura T. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease[J].{H}Journal of Biochemistry,2012.179-187.
9Kiyama S,Yamada T,Iwata H. Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation[J].{H}Journal of Gastroenterology and Hepatology,2008.e471-e476.
